27312487|t|Osteopontin expression in co-cultures of human squamous cell carcinoma -derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation
27312487|a|This study evaluated the temporal expression of osteopontin (OPN) in co-cultures of human osteoblastic cells (SAOS-2) and oral squamous cell carcinoma (OSCC)-derived cells (SCC9) and examined the effects of osteoblast -derived OPN on the neoplastic cell phenotype. Additionally, the effects of these co-cultures on subsequent osteoclastic activity were explored. SCC9 cells were plated on Transwell® membranes that were either coated or not coated with Matrigel and were then co-cultured with SAOS-2 cells during the peak of OPN expression. SCC9 cells exposed to OPN -silenced SAOS-2 cultures and SCC9 cells cultured alone served as controls. SCC9 cells were quantitatively evaluated for cell adhesion, proliferation, migration, and invasion into Matrigel. The impact of co-culturing SAOS-2 and SCC9 cells on the resorptive capacity of U-937 -derived osteoclastic cells was also investigated. Furthermore, a reciprocal induction of SAOS-2 and SCC9 cells in terms of OPN expression over the co-culture interval was identified. SAOS-2 -secreted OPN altered the SCC9 cell phenotype, leading to enhanced cell adhesion and proliferation and higher Matrigel invasion. This invasion was also enhanced, albeit to a lesser degree, by co-culture with OPN - silenced SAOS-2 cells. Cell migration was not affected. Co-culture with SAOS-2 cells -mainly during the period of peak OPN expression -promoted over-expression of IL-6 and IL-8 by SCC9 cells and enhanced the resorptive capacity of osteoclastic cells. Taken together, these results suggest that osteoblast -derived OPN affects the interactions among OSCC -derived epithelial cells, osteoblasts, and osteoclasts, which could contribute to the process of bone destruction during bone invasion by OSCC.
27312487	0	11	Osteopontin	T116,T123	C0069676
27312487	12	22	expression	T045	C1171362
27312487	26	37	co-cultures	T025	C0007600
27312487	41	46	human	T016	C0086418
27312487	47	70	squamous cell carcinoma	T191	C0007137
27312487	80	85	cells	T025	C0085983
27312487	90	108	osteoblastic cells	T025	C0029418
27312487	117	124	effects	T080	C1280500
27312487	132	147	neoplastic cell	T025	C0597032
27312487	148	157	phenotype	T032	C1318444
27312487	162	174	osteoclastic	T025	C0029431
27312487	175	185	activation	T043	C1326120
27312487	191	196	study	T062	C2603343
27312487	197	206	evaluated	T169	C1292732
27312487	211	219	temporal	T079	C2362314
27312487	220	230	expression	T045	C1171362
27312487	234	245	osteopontin	T116,T123	C0069676
27312487	247	250	OPN	T116,T123	C0069676
27312487	255	266	co-cultures	T025	C0007600
27312487	270	275	human	T016	C0086418
27312487	276	294	osteoblastic cells	T025	C0029418
27312487	296	302	SAOS-2	T025	C0029418
27312487	308	336	oral squamous cell carcinoma	T191	C0585362
27312487	338	342	OSCC	T191	C0585362
27312487	352	357	cells	T025	C0085983
27312487	359	363	SCC9	T025	C0085983
27312487	369	377	examined	T033	C0332128
27312487	382	389	effects	T080	C1280500
27312487	393	403	osteoblast	T025	C0029418
27312487	413	416	OPN	T116,T123	C0069676
27312487	424	439	neoplastic cell	T025	C0597032
27312487	440	449	phenotype	T032	C1318444
27312487	469	476	effects	T080	C1280500
27312487	486	497	co-cultures	T025	C0007600
27312487	512	524	osteoclastic	T025	C0029431
27312487	525	533	activity	T043	C0007613
27312487	549	559	SCC9 cells	T025	C0085983
27312487	575	595	Transwell® membranes	T073	C1706182
27312487	613	619	coated	T080	C1522408
27312487	639	647	Matrigel	T116,T130	C0065749
27312487	662	673	co-cultured	T059	C0007585
27312487	679	691	SAOS-2 cells	T025	C0029418
27312487	711	714	OPN	T116,T123	C0069676
27312487	715	725	expression	T045	C1171362
27312487	727	737	SCC9 cells	T025	C0085983
27312487	749	752	OPN	T116,T123	C0069676
27312487	763	769	SAOS-2	T025	C0029418
27312487	770	778	cultures	T025	C0007600
27312487	783	793	SCC9 cells	T025	C0085983
27312487	794	802	cultured	T059	C0007585
27312487	819	827	controls	T096	C0009932
27312487	829	839	SCC9 cells	T025	C0085983
27312487	845	869	quantitatively evaluated	T081	C0034384
27312487	874	887	cell adhesion	T043	C0007577
27312487	889	902	proliferation	T043	C0596290
27312487	904	913	migration	T043	C1622501
27312487	919	927	invasion	T046	C2699153
27312487	933	941	Matrigel	T116,T130	C0065749
27312487	957	969	co-culturing	T059	C0007585
27312487	970	976	SAOS-2	T025	C0029418
27312487	981	991	SCC9 cells	T025	C0085983
27312487	1022	1027	U-937	T025	C0600531
27312487	1037	1055	osteoclastic cells	T025	C0029431
27312487	1065	1077	investigated	T169	C1292732
27312487	1094	1104	reciprocal	T080	C1882911
27312487	1105	1114	induction	T169	C0205263
27312487	1118	1124	SAOS-2	T025	C0029418
27312487	1129	1139	SCC9 cells	T025	C0085983
27312487	1152	1155	OPN	T116,T123	C0069676
27312487	1156	1166	expression	T045	C1171362
27312487	1176	1186	co-culture	T025	C0007600
27312487	1212	1218	SAOS-2	T025	C0029418
27312487	1229	1232	OPN	T116,T123	C0069676
27312487	1245	1254	SCC9 cell	T025	C0085983
27312487	1255	1264	phenotype	T032	C1318444
27312487	1277	1285	enhanced	T081	C0205217
27312487	1286	1299	cell adhesion	T043	C0007577
27312487	1304	1317	proliferation	T043	C0596290
27312487	1329	1337	Matrigel	T116,T130	C0065749
27312487	1338	1346	invasion	T046	C2699153
27312487	1353	1361	invasion	T046	C2699153
27312487	1411	1421	co-culture	T025	C0007600
27312487	1427	1430	OPN	T028	C2987232
27312487	1433	1441	silenced	T045	C0598496
27312487	1442	1454	SAOS-2 cells	T025	C0029418
27312487	1456	1470	Cell migration	T043	C1622501
27312487	1489	1499	Co-culture	T025	C0007600
27312487	1505	1517	SAOS-2 cells	T025	C0029418
27312487	1552	1555	OPN	T116,T123	C0069676
27312487	1556	1566	expression	T045	C1171362
27312487	1577	1592	over-expression	T045	C1171362
27312487	1596	1600	IL-6	T116,T129	C0021760
27312487	1605	1609	IL-8	T116,T129	C0079633
27312487	1613	1623	SCC9 cells	T025	C0085983
27312487	1641	1651	resorptive	T052	C1948029
27312487	1664	1682	osteoclastic cells	T025	C0029431
27312487	1706	1713	results	T033	C0683954
27312487	1727	1737	osteoblast	T025	C0029418
27312487	1747	1750	OPN	T116,T123	C0069676
27312487	1751	1758	affects	T169	C0392760
27312487	1763	1775	interactions	T043	C0007582
27312487	1782	1786	OSCC	T191	C0585362
27312487	1796	1812	epithelial cells	T025	C0014597
27312487	1814	1825	osteoblasts	T025	C0029418
27312487	1831	1842	osteoclasts	T025	C0029431
27312487	1874	1881	process	T067	C1522240
27312487	1885	1901	bone destruction	T047	C0238790
27312487	1909	1913	bone	T023	C0262950
27312487	1914	1922	invasion	T046	C2699153
27312487	1926	1930	OSCC	T191	C0585362